Comprehensive Clinical Prediction Rule for Acute Heart Failure

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChinese University of Hong Kong

About this trial

The goal of this prospective observational cohort study is to establish a comprehensive clinical prediction rule integrating clinical characteristics, point-of-care testing (POCT) of NT-proBNP, an 8-point LUS, and a rapid cardiac assessment using bedside echocardiography for diagnosing acute heart failure (AHF) in the emergency department. A clinical prediction rule with high diagnostic accuracy will minimize delays and misdiagnoses, as well as the potential harm they may cause to patients. The primary outcome measure is the adjudicated AHF diagnosis. Secondary outcome measures include ED and discharge diagnosis of the patients.

Eligibility criteria

Qualifiers

Adult (aged ≥ 18 years)

Suspected AHF or acute dyspnea

Symptoms include shortness of breath, swelling of legs, orthopnea, paroxysmal nocturnal dyspnoea, exertional dyspnea or weight gain

Disqualifiers

Trauma patients

Pregnancy

Unstable patients requiring invasive airway intervention

Patients who refuse to participate

Trial design

Treatments tested in this trial

  • Acute Heart Failure Diagnostic Method

Treatment groups

560 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Chinese University of Hong Kong

Lead sponsor

Prince of Wales Hospital, Shatin, Hong Kong

Collaborator

The University of Hong Kong

Collaborator

Tuen Mun Hospital, Hospital Authority, Hong Koong

Collaborator

Queen Mary Hospital, Hong Kong

Collaborator